Lumakras

Lumakras Coupons & Discount Card - Compare Prices Near You

Lumakras (sotorasib) is prescribed for adults with metastatic non-small cell lung cancer (NSCLC) that exhibits a KRAS G12C mutation, particularly after other treatments have failed. This oral medication is taken once daily and works by inhibiting the KRAS G12C protein, which is responsible for promoting the uncontrolled growth of cancer cells. By targeting this specific mutation, Lumakras effectively helps to prevent tumor growth. Note that while Lumakras offers a convenient treatment option, it can lead to common side effects like stomach upset and fatigue. Always consult with your healthcare provider for advice tailored to your medical needs before starting any new medication.
Our Lumakras coupons are free to use. You can print the coupon, email it to yourself, or receive the Lumakras coupon via text message. To get your free discount, show the pharmacist your Lumakras savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Lumakras prices will update based on your prescription needs. Above our Lumakras coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Lumakras savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.

My prescription

Edit

120MG, Lumakras (30 Tablets)

Select pharmacy

Pharmacy logo

Rite Aid

$2698.83

COUPON PRICE
Pharmacy logo

Walgreens

$2814.00

COUPON PRICE

Lumakras savings card

Show this card to your pharmacist
Pharmacy logo

Rite Aid

$2698.83

BIN

ID

PCN

GRP

019876

LH8B1ED171

CHIPPO

LHX

Powered by

This card is not insurance

Related KRAS inhibitor prescriptions

coupons from$3797.25Save 72%

More prescriptions for lung cancer

coupons from$2454.45Save 72%
coupons from$20961.09Save 72%
coupons from$5618.61 
coupons from$6301.64Save 72%
coupons from$11983.39Save 72%
coupons from$4963.9 
coupons from$11887.84Save 72%
coupons from$16643.83 

Related KRAS inhibitor prescriptions

Krazati Save 72%coupons from $3797.25

More prescriptions for lung cancer

Alecensa Save 72%coupons from $2454.45
Alunbrig Save 72%coupons from $20961.09
Gavretocoupons from $5618.61
Tabrecta Save 72%coupons from $6301.64
Xalkori Save 72%coupons from $11983.39
Zykadiacoupons from $4963.9
Gilotrif Save 72%coupons from $11887.84
Vizimprocoupons from $16643.83

Lumakras dosage forms

The average cost for 30 Tablets of Lumakras at 120MG is $2742.19 with a free coupon. This is 27.97% off the average retail price of $9804.31
DosageQuantityPrice fromPer unit
120MG30 Tablets$2742.19$91.41
320MG30 Tablets$7309.6$243.65
240MG30 Tablets$5482.63$182.75

Lumakras Warnings

Here are the essential safety and warning details regarding the use of Lumakras (sotorasib). It is crucial to understand these points and discuss any questions or concerns with your healthcare provider.

  • Liver Injury: Lumakras may potentially harm your liver. To mitigate this risk, regular blood tests are necessary to monitor liver function. These tests are typically conducted before initiating treatment, every three weeks at the beginning of the treatment, and then at reduced frequency. Liver damage has been reported within the first two months of treatment. Be vigilant for symptoms such as right-sided abdominal pain, yellowing of the skin or eyes, or dark urine. If liver damage is suspected, your healthcare provider may pause your treatment until liver function stabilizes, possibly resuming at a lower dosage.

  • Lung Damage: Though uncommon, Lumakras can lead to severe lung issues, including life-threatening conditions. Such problems have been observed within the first four months of treatment. Report any new or worsening cough, breathing difficulties, or fevers to your healthcare provider immediately. Medication may need to be discontinued while lung function is assessed.

No explicit contraindications have been identified for Lumakras; however, always consult your healthcare provider for personalized advice based on your health status and history.

Lumakras Side Effects

When taking this medication, some common side effects may include diarrhea, muscle or bone pain, fatigue, nausea, and cough. These are generally mild, but if they persist or worsen, contact your healthcare provider for advice. Other potential side effects may include vomiting, constipation, stomach pain, shortness of breath, or swelling. While these are less common, it's important to monitor any changes and consult your healthcare provider if you experience them.

There are also rare but serious side effects that require immediate medical attention. Signs of liver injury, such as right-sided stomach pain, yellowing of the eyes or skin, or dark urine, should be addressed urgently. Similarly, lung damage, indicated by symptoms like cough, shortness of breath, or fever, is a critical concern. Allergic reactions, though very rare, may present as a rash, itching, swelling, severe dizziness, or trouble breathing, and necessitate prompt medical attention.

Rashes are a common occurrence and often not serious, but it's crucial to seek medical help if you develop one, as it could signal a severe reaction. Always stay vigilant and report any unexplained or severe side effects to your healthcare provider for further guidance.

Lumakras Interactions

Sotorasib can be affected by other medications, altering its effectiveness. Drugs such as rifamycins (e.g., rifabutin) and certain seizure medications (e.g., carbamazepine, phenytoin) can influence how sotorasib is processed in your body. Additionally, sotorasib may accelerate the elimination of some medications, impacting their effectiveness. Examples include daridorexant, elacestrant, lonafarnib, mavacamten, quizartinib, and revumenib.

Furthermore, sotorasib may reduce the efficiency of hormonal birth control methods like pills, patches, or rings, potentially leading to unintended pregnancy. It's important to consult with your healthcare provider about using additional reliable birth control methods while taking this medication. If you experience unusual spotting or breakthrough bleeding, contact your doctor, as these could indicate reduced birth control effectiveness.

Lumakras FAQs
What is the survival rate for lumakras?

The survival rate for Lumakras (sotorasib) can vary depending on several factors, including the specific type and stage of cancer being treated, as well as individual patient characteristics. Lumakras is primarily used for treating non-small cell lung cancer (NSCLC) with a specific KRAS G12C mutation. Clinical trials have shown that Lumakras can lead to a significant reduction in tumor size and progression-free survival in some patients. However, exact survival rates can differ, and it is important for patients to discuss their individual prognosis and treatment outcomes with their healthcare provider.

The cost of Lumakras can vary depending on factors such as insurance coverage, pharmacy, and location. On average, the monthly cost without insurance can be several thousand dollars. It is recommended to check with a specific pharmacy or insurance provider for the most accurate and up-to-date pricing information.

Lumakras (sotorasib) is not classified as a traditional chemotherapy drug. It is a targeted therapy used to treat certain types of non-small cell lung cancer (NSCLC) with a specific genetic mutation known as KRAS G12C. Targeted therapies like Lumakras work by specifically targeting cancer cells with this mutation, which can lead to fewer side effects compared to traditional chemotherapy.

Lumakras is used for the treatment of adults with non-small cell lung cancer (NSCLC) that has a specific mutation in the KRAS G12C gene. It is typically prescribed for patients whose cancer has progressed after receiving at least one prior systemic therapy.

Yes, sotorasib can be considered expensive. The cost of this medication can vary depending on factors such as insurance coverage, location, and healthcare provider. Patients are encouraged to discuss the cost and potential financial assistance options with their healthcare provider or pharmacist.

Related Drugs